BioCentury
ARTICLE | Clinical News

BB-2516: Began U.K. tests

November 21, 1994 8:00 AM UTC

British Biotech plc (BBIOY), Oxford, U.K. Product: Batimastat matrix metalloproteinase inhibitor Indication: Malignant ascites of late stage ovarian and abdominal cancers Status: Began Phase III testi...